SIA
BNR

SkyView Investment Advisors’s Burning Rock Biotech BNR Stock Holding History

SkyView Investment Advisors’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$87K – 334
2025
Q3 		$87K Hold
10,000
– – 0.01% 272
2025
Q2 		$32K Hold
10,000
– – ﹤0.01% 277
2025
Q1 		$45K Hold
10,000
– – 0.01% 271
2024
Q4 		$68K Hold
10,000
– – 0.01% 244
2024
Q3 		$33K Hold
10,000
– – 0.01% 248
2024
Q2 		$64K Buy
+10,000
New +$76.1K 0.01% 279

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CL
CRCM LP San Francisco, California $141M AUM 153.09% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RWMG
Redwood Wealth Management Group Medford, New Jersey $232M AUM 22.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SkyView Investment Advisors's BNR Position: Q4 2025 in Review

SkyView Investment Advisors sold out of Burning Rock Biotech (BNR) in Q4 2025, closing a stake of 10,000 shares — an estimated $87K sold.

SkyView Investment Advisors first reported a position in BNR in Q2 2024 and held it in 6 quarters. The position peaked at $87K in Q3 2025. 16 funds tracked by Wall St. Rank hold BNR as of Q4 2025.

  • SkyView Investment Advisors reported no remaining Burning Rock Biotech position as of Q4 2025 after selling out during the quarter.
  • SkyView Investment Advisors sold 10,000 Burning Rock Biotech shares in Q4 2025, an estimated $87K.
  • SkyView Investment Advisors first reported a position in Burning Rock Biotech in Q2 2024 and held it in 6 quarters.
  • SkyView Investment Advisors's Burning Rock Biotech position peaked at $87K in Q3 2025.
  • 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2025.

Based on SkyView Investment Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.